Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes
Effects of Blood Flow Restriction Training on Upper and Lower Limb Neuromuscular Function, Body Composition, Physiological Responses, and Sport Performance in Artistic Jump Rope Athletes: A Randomized Controlled Trial
The goal of this randomized controlled trial is to investigate whether blood flow restriction training can improve physical function and sports performance in artistic jump rope athletes. The study will include 30 healthy artistic jump rope athletes aged 18 to 25 years. The main questions this study aims to answer are:
- Does blood flow restriction training improve neuromuscular function compared with conventional training?
- Does blood flow restriction training improve muscle strength, power, body composition, physiological responses, and artistic jump rope performance?
Researchers will compare participants receiving blood flow restriction training with participants performing conventional training to determine whether blood flow restriction training provides additional benefits. Participants will complete an 8-week training program and undergo assessments before and after the intervention, including muscle function tests, physical performance tests, body composition measurements, and physiological response evaluations.
Panoramica dello studio
Stato
Descrizione dettagliata
Blood flow restriction (BFR) training is an exercise method that uses external pressure to partially restrict blood flow during exercise. This method may allow individuals to achieve improvements in muscle function and physical performance while using lower exercise loads. However, the effects of BFR training in artistic jump rope athletes are not fully understood.
The purpose of this study is to examine the effects of an 8-week blood flow restriction training program on neuromuscular function, body composition, physiological responses, and sport-specific performance in artistic jump rope athletes.
Approximately 30 healthy artistic jump rope athletes aged 18 to 25 years will participate in this study. Participants will be randomly assigned to either a blood flow restriction training group or a conventional training group. Both groups will continue their regular artistic jump rope training during the intervention period. The blood flow restriction training group will complete selected training sessions with individualized blood flow restriction pressure.
Before and after the 8-week intervention, researchers will assess changes in neuromuscular function, upper and lower limb muscle strength, explosive power, jump rope-specific performance, body composition, heart rate responses, and blood lactate responses.
This study may provide information about whether blood flow restriction training can be used as an effective training strategy to improve physical function and performance characteristics in artistic jump rope athletes.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Shijun Jin, student
- Numero di telefono: 86+15670976576
- Email: 15670976576@163.com
Backup dei contatti dello studio
- Nome: Liubin Fu, Student
- Numero di telefono: 86+15329763941
- Email: 1076102965@qq.cn
Luoghi di studio
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Cina, 200000
- Shanghai University of Sport, School of Physical EducationKun
-
Contatto:
- Kun Zhu, Professor
- Numero di telefono: 86+13938431772
- Email: zhukun@sus.edu.cn
-
Contatto:
- Shijun Jin, Student
- Numero di telefono: 86+15670976576
- Email: applecatt2002@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Adults aged 18 to 25 years.
- Current artistic jump rope athletes with at least 2 years of regular artistic jump rope training experience.
- Participants who are able to perform artistic jump rope skills and complete all study-related assessments and training procedures.
- Participants who are physically healthy and have no medical conditions that may interfere with exercise testing or blood flow restriction training.
- Participants who have no acute or chronic musculoskeletal injuries affecting the upper limbs, lower limbs, or trunk.
- Participants who voluntarily agree to participate and provide written informed consent before enrollment.
Exclusion Criteria:
- Participants younger than 18 years or older than 25 years.
- Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation disorders, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise safety.
- Presence of acute or chronic musculoskeletal injuries, including injuries involving muscles, joints, ligaments, tendons, or bones, that prevent safe completion of study procedures.
- Significant pain, severe fatigue, insufficient recovery, poor sleep condition, or other health conditions that may affect exercise performance or participant safety.
- Use of medications, nutritional supplements, or sports supplements within the previous week that may influence cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance.
- Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
- Inability to understand the study procedures or inability to complete required assessments, including physical performance tests, blood flow restriction training, or blood lactate testing.
- Refusal to participate in blood flow restriction training or withdrawal of informed consent during the study.
Exclusion Criteria:
1. Age younger than 18 years or older than 25 years. 2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation abnormalities, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise testing or blood flow restriction training safety.
3. Current acute or chronic injuries involving muscles, joints, ligaments, tendons, or bones that prevent safe completion of study procedures.
4. Severe fatigue, poor recovery status, significant pain, insufficient sleep, or other conditions that may influence exercise performance or participant safety.
5. Use of medications, nutritional supplements, or sports supplements that may affect cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance within the previous week.
6. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
7. Inability or unwillingness to complete study assessments, blood flow restriction training, blood lactate testing, or other required procedures.
8. Withdrawal of consent or inability to comply with the study protocol during the intervention period.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Blood Flow Restriction Training Group
|
An 8-week blood flow restriction training program combined with regular artistic jump rope training.
External pressure will be applied using a blood flow restriction device during selected training sessions.
|
|
Comparatore attivo: Conventional Training Group
|
An 8-week conventional artistic jump rope training program without blood flow restriction.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Neuromuscular Function Assessed by Surface Electromyography and Maximal Voluntary Contraction
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Neuromuscular function will be assessed using surface electromyography (sEMG) and maximal voluntary contraction (MVC) testing.
Outcome measures include muscle activation amplitude, root mean square (RMS, μV), integrated electromyography (iEMG, μV·s), mean power frequency (MPF, Hz), and maximal voluntary contraction force (N).
|
Baseline and after 8 weeks of intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Upper Limb Muscle Strength Assessed by Hand Grip Strength Test
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Upper limb muscle strength will be assessed using grip strength testing.
The outcome measure is maximal voluntary grip force (kg) measured during maximal effort contraction.
|
Baseline and after 8 weeks of intervention
|
|
Change in One-Repetition Maximum Strength
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Maximal muscle strength will be assessed using one-repetition maximum (1RM) testing.
The outcome measure is the maximal load successfully completed during the strength test (kg).
|
Baseline and after 8 weeks of intervention
|
|
Change in Lower Limb Explosive Power Assessed by Three-Dimensional Force Platform
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Lower limb explosive power and jump performance will be assessed using a three-dimensional force platform during jump testing.
Outcome measures include jump height (cm), peak ground reaction force (N), peak power output (W), and rate of force development (N/s).
|
Baseline and after 8 weeks of intervention
|
|
Change in Upper Limb Anaerobic Power During Wingate Test
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Upper limb anaerobic power will be assessed using a 30-second upper limb Wingate test performed on an arm crank ergometer.
Outcome measures include peak power output (W), mean power output (W), relative peak power output (W/kg), total work (J), and fatigue index (%).
|
Baseline and after 8 weeks of intervention
|
|
Change in Lower Limb Anaerobic Power During Wingate Test
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Lower limb anaerobic power will be assessed using Wingate cycling tests.
Outcome measures include peak power output (W), mean power output (W), relative peak power output (W/kg), total work (J), and fatigue index (%).
A 6-second Wingate test will assess explosive power, and a 30-second Wingate test will assess anaerobic capacity and fatigue-related performance.
|
Baseline and after 8 weeks of intervention
|
|
Change in Body Composition Assessed by Dual-Energy X-ray Absorptiometry
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Body composition will be assessed using dual-energy X-ray absorptiometry (DXA).
Outcome measures include body mass (kg), body fat percentage (%), fat mass (kg), lean body mass (kg), and bone mineral content (kg).
|
Baseline and after 8 weeks of intervention
|
|
Change in Physiological Responses During Exercise
Lasso di tempo: Baseline and 8 weeks after intervention
|
Physiological responses will be assessed using heart rate monitoring and blood lactate testing.
Outcome measures include resting heart rate (beats/min), peak heart rate (beats/min), heart rate recovery (beats/min), and blood lactate concentration (mmol/L).
|
Baseline and 8 weeks after intervention
|
|
Change in Dynamic Balance Performance
Lasso di tempo: Baseline and 8 weeks after intervention
|
Dynamic balance performance will be assessed using the Y Balance Test.
Outcome measures include anterior reach distance (cm), posteromedial reach distance (cm), posterolateral reach distance (cm), and composite reach score (%).
|
Baseline and 8 weeks after intervention
|
|
Change in Short-Duration Rope Turning Performance
Lasso di tempo: Baseline and after 8 weeks of intervention
|
Short-duration rope turning performance will be assessed using a 10-second maximal rope turning test.
Outcome measures include total repetitions completed within 10 seconds and average movement frequency (repetitions/s).
|
Baseline and after 8 weeks of intervention
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: kun Zhu, Professor, Shanghai University of Sport
- Direttore dello studio: Jing Wang, Student, Shanghai University of Sport
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 102772026RT119
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .